Back to News and Publications

Selected 2015 Life Sciences Transactions

  • 5.6.2015
Recognized both globally and nationally as a leading life sciences practice, WilmerHale has four decades of experience representing biotechnology, pharmaceutical and medical device companies at all stages of growth, as well as venture capitalists and investment banks.

2015-WH-LifeSciences-Deals

Not sure where to start?

Let our Knowledge Navigator direct you to content specific to where you are on your journey.

Get Started!
Featured
blog-launch-550x370

This blog post explores certain specific terms in term sheets that will create legally binding obligations.

Schall launch feature

Partner Gary Schall shares some practical advice about term sheets: Don’t attempt any transaction without one.

Rss Feed
4.19.2024
Rise of the Ronin is the dark horse of the March 22 releases | Kaser Focus 
4.19.2024
Why LLMs are predicting the future of compliance and risk management 
4.19.2024
Lorelei and the Laser Eyes preview: Overclock your thinking cap 
Build
Document Generator  
Startup Dictionary  
Research
4.2.2024
Corporate Transparency Act: What is a Reporting Company?
4.1.2024
Corporate Transparency Act: Entities Formed in Early January Must Comply with the CTA as Early as Today
3.26.2024
Corporate Transparency Act: First Wave of Required Reports Due Starting on March 31, 2024